National Institutes of Health: all 11,571 studies

Page 10 of 116. Open to participants first (946), then studies with results posted, then the rest; newest registration first within each.

• Study of New Magnetic Resonance Imaging Methods of the BrainRecruitingNCT00004577
• Study of Inherited Neurological DisordersRecruitingNCT00004568
• Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital ToxoplasmosisRecruitingNCT00004317Phase 4
• Genetic Studies of Insulin and DiabetesRecruitingNCT00001987
• Immune System Related Kidney DiseaseRecruitingNCT00001979
• Study of Skin Tumors in Tuberous SclerosisRecruitingNCT00001975
• Evaluation of Patients With Liver DiseaseRecruitingNCT00001971
• Diabetes and Heart Disease Risk in BlacksRecruitingNCT00001853
• COLLECT BLOOD/RESEARCH USERecruitingNCT00001846
• Evaluation for NCI Surgery Branch Clinical Research ProtocolsRecruitingNCT00001823
• Evaluation of Patients With HAM/TSPRecruitingNCT00001778
• Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and the McCune-Albright SyndromeRecruitingNCT00001727
• Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic InfectionRecruitingNCT00001645
• Screening for Hematology Branch ProtocolsEnrolling by invitationNCT00001620
• An Investigation of Pituitary Tumors and Related Hypothalmic DisordersRecruitingNCT00001595
• A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control PopulationsRecruitingNCT00001539
• Role of Genetic Factors in the Development of Lung DiseaseRecruitingNCT00001532
• Improved Methods of Cell Selection for Bone Marrow Transplant AlternativesRecruitingNCT00001529
• Genetic Analysis of Immune DisordersRecruitingNCT00001467
• Study of the Disease Process of LymphangioleiomyomatosisRecruitingNCT00001465
• Clinical and Basic Investigations Into Hermansky-Pudlak SyndromeRecruitingNCT00001456
• Activation and Function of Eosinophils in Conditions With Blood or Tissue EosinophiliaRecruitingNCT00001406
• Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and GranulocytesRecruitingNCT00001405
• Study of Proteus Syndrome and Related Congenital DisordersRecruitingNCT00001403
• Familial Mediterranean Fever and Related Disorders: Genetics and Disease CharacteristicsRecruitingNCT00001373
• Study of Systemic Lupus ErythematosusRecruitingNCT00001372
• Studies of Blood Flow to the Brain During ThoughtRecruitingNCT00001360
• Detection and Characterization of Host Defense DefectsRecruitingNCT00001355
• Fungal Infection SusceptibilityRecruitingNCT00001352
• Evaluation and Long-Term Follow-up of Patients With Inflammatory DisordersEnrolling by invitationNCT00001351
• Study of Autoimmune Lymphoproliferative Syndrome (ALPS)RecruitingNCT00001350
• Viral Load in Blood and Lymph Tissues in People Living With HIVRecruitingNCT00001316
• Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIVRecruitingNCT00001281
• Diagnosing and Treating Low Blood Sugar LevelsRecruitingNCT00001276
• Human Movement DatabaseRecruitingNCT00001252
• Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)RecruitingNCT00001248
• Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI)RecruitingNCT00001244
• Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant DisordersRecruitingNCT00001238
• Host Response to Infection and Treatment in Filarial DiseasesRecruitingNCT00001230
• Genetic Studies of Lysosomal Storage DisordersEnrolling by invitationNCT00001215
• Botulinum Toxin for the Treatment of Involuntary Movement DisordersRecruitingNCT00001208
• Natural History of Treated Neurocysticercosis and Long-Term OutcomesRecruitingNCT00001205
• Psychological Benefits of a Normalized Camping Experience for Children With CancerRecruitingNCT00001186
• Immune Regulation in Ulcerative Colitis or Crohn s DiseaseRecruitingNCT00001184
• Studies on Tumors of the ThyroidRecruitingNCT00001160
• Natural History of Thyroid Function DisordersRecruitingNCT00001159
• Phase 1 Study on Bioavailability, Food Effect, and Drug-Drug Interaction of ALG-097558 Tablets in Healthy VolunteersCompletedNCT06945276Phase 1Results posted
• Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical CarcinomasTerminatedNCT06865677Phase 2Results posted
• Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)CompletedNCT06729606Phase 3Results posted
• Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)CompletedNCT06729593Phase 3Results posted
• Feasibility of Measuring Volume of Inspiration Via Noninvasive Motion SensorsCompletedNCT06609616Not applicableResults posted
• Study of the Infectivity, Safety and Immunogenicity of Two Recombinant, Live-Attenuated, B/HPIV3 Vectored Vaccines Expressing the Fusion Glycoprotein of HMPV Delivered by Nasal Spray to HPIV3-Seropositive Children 24 to <60 Months of AgeCompletedNCT06546423Phase 1Results posted
• Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot StudyTerminatedNCT06503159Not applicableResults posted
• L9LS MAb in Malian InfantsCompletedNCT06461026Phase 1Results posted
• Phase 1, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of an Enterovirus D68-specific Monoclonal Antibody in Healthy AdultsCompletedNCT06444048Phase 1Results posted
• Testing Ipatasertib as Potentially Targeted Treatment in Cancers With AKT Genetic Changes (MATCH - Subprotocol Z1K)Active, not recruitingNCT06400251Phase 2Results posted
• Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Expression (MATCH - Subprotocol Z1H)Active, not recruitingNCT06400238Phase 2Results posted
• Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E)Active, not recruitingNCT06390852Phase 2Results posted
• Testing Palbociclib (PD-0332991) as Potentially Targeting Treatment in Cancers With CDK4 or CDK6 Amplification (MATCH - Subprotocol Z1C)Active, not recruitingNCT06390839Phase 2Results posted
• Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V)Active, not recruitingNCT06390826Phase 2Results posted
• Testing Afatinib as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH - Subprotocol A)Active, not recruitingNCT06385483Phase 2Results posted
• Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)Active, not recruitingNCT06360588Phase 2Results posted
• Testing Crizotinib as Potentially Targeted Treatment in Cancers With MET Exon 14 Deletion Genetic Changes (MATCH - Subprotocol C2)Active, not recruitingNCT06360575Phase 2Results posted
• Testing GDC-0449 (Vismodegib) as Potentially Targeted Treatment in Cancers With Smoothened or Patched 1 Mutant Tumors (MATCH - Subprotocol T)Active, not recruitingNCT06357988Phase 2Results posted
• Testing Crizotinib as Potentially Targeted Treatment in Cancers With MET Genetic Changes (MATCH - Subprotocol C1)Active, not recruitingNCT06357975Phase 2Results posted
• Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Mutations or Fusions (MATCH - Subprotocol K2)Active, not recruitingNCT06351371Phase 2Results posted
• SXC-2023 Cocaine Interaction StudyCompletedNCT06343532Phase 1Results posted
• Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Amplifications (MATCH-Subprotocol K1)Active, not recruitingNCT06308822Phase 2Results posted
• Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)Active, not recruitingNCT06303167Phase 2Results posted
• Deprescribing Potentially Inappropriate Medications in the Emergency Department for Persons Living With DementiaCompletedNCT06273917Not applicableResults posted
• NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Early Feasibility StudyTerminatedNCT06269640Not applicableResults posted
• Safety Study of SLV213 for the Treatment of COVID-19.TerminatedNCT06146374Phase 1Results posted
• Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ FunctionActive, not recruitingNCT06145282Phase 1/2Results posted
• Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)Active, not recruitingNCT06136897Phase 2Results posted
• Estradiol Therapy In Transgender Women to Research Interactions With HIV TherapyTerminatedNCT06005610Phase 2Results posted
• JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow FailureActive, not recruitingNCT05998408Phase 1/2Results posted
• JAK/STAT Inhibition in CNS Kohlmeier-Degos DiseaseCompletedNCT05998395Phase 1/2Results posted
• Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal CancerActive, not recruitingNCT05996523Phase 2Results posted
• Effect of Bismuth Subsalicylate on the Gut Microbiome and Host Response in Healthy AdultsCompletedNCT05930197Phase 1Results posted
• Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic SyndromesTerminatedNCT05918055Phase 1/2Results posted
• Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 DeficiencyActive, not recruitingNCT05907746Phase 2Results posted
• Study of the Selective GlyT1 Inhibitor Bitopertin for Steroid-Refractory Diamond-Blackfan AnemiaCompletedNCT05828108Phase 1/2Results posted
• A Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding a Native-like HIV Env Trimer and Interleukin-12 (INO-6160), Alone or in a Prime-boost Regimen With 3M-052-AF + Alum Adjuvanted VRC HIV Env Trimer 4571 in Adult Participants Without HIVCompletedNCT05828095Phase 1Results posted
• L9LS MAb in Malian AdultsCompletedNCT05816330Phase 2Results posted
• Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding NP-GT8 and IL-12, With or Without a TLR-agonist-Adjuvanted HIV Env Trimer 4571 Boost, in Adults Without HIVCompletedNCT05781542Phase 1Results posted
• PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)TerminatedNCT05780541Phase 3Results posted
• MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)CompletedNCT05780463Phase 3Results posted
• AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)CompletedNCT05780437Phase 3Results posted
• BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)CompletedNCT05780424Phase 3Results posted
• VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)CompletedNCT05780281Phase 3Results posted
• LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)CompletedNCT05780268Phase 3Results posted
• Pharmacokinetic Study of IV Artesunate to Treat Children With Severe MalariaCompletedNCT05750459Phase 4Results posted
• A Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for MpoxCompletedNCT05740982Phase 2Results posted
• PTH-independent Effects of EncaleretCompletedNCT05735015Phase 2Results posted
• Assessment of Safety Profile of MVA-BN Vaccine in the PALM-007 Study in DRCCompletedNCT05734508Phase 4Results posted
• Testing the Combination of Anti-cancer Drugs Atezolizumab and Tiragolumab in People With Advanced Stage Rare Cancers, RARE3 TrialActive, not recruitingNCT05715281Phase 2Results posted
• Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) in JIATerminatedNCT05710640Phase 2Results posted
• Trial to Model Primary, Secondary, and Tertiary Dengue Using a Monovalent VaccineCompletedNCT05691530Phase 1Results posted
• NHLBI Transmural Electrosurgery LeafLet Traversal And Laceration Evaluation (TELLTALE) BASILICA-TAVR TrialCompletedNCT05666713Not applicableResults posted
• Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)CompletedNCT05645757Phase 1Results posted

← National Institutes of Health overview and focus areas